News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|July 24, 2015

Photographer Bill Aron Discusses His Book

Author(s)Bill Aron

Photographer Bill Aron discusses his book.

Advertisement

Photographer Bill Aron discusses his book. To learn more about Bill Aron visit: http://www.billaron.com/

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
The FDA has granted approval to treatment with Rubraca for some adult patients with previously-treated metastatic castration-resistant prostate cancer: © stock.adobe.com.

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

ByAlex Biese
December 17th 2025
Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time.

A Patient’s Journey Through Remission and Mental Health With Non-Hodgkin Lymphoma

ByJace Yawnick
December 17th 2025
Dr. Raghav Sundar

Expert Explains Nutrition and Weight Loss Challenges in Gastric Cancer

ByRaghav Sundar, M.B.B.S., M.R.C.P., M.Med.
December 16th 2025
Image of woman.

When Chemotherapy Side Effects Sent Her to the ICU

ByLindsey Gunter
December 16th 2025
Newly diagnosed with stage 3 prostate adenocarcinoma? Understand your diagnosis, explore multimodality treatment options, potential side effects, and key questions to ask your oncologist for an informed cancer journey.

Stage 3 Prostate Cancer: A Guide to Diagnosis, Treatment, and Next Steps

ByGina Mauro
December 14th 2025
Advertisement
Advertisement

Trending on CURE

1

Navigating the Holidays When Cancer Never Quite Leaves

2

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

3

Key Blood Cancer Advances for Patients From the 2025 ASH Annual Meeting

4

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

5

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.